Arterial stiffness assessed by the pulse wave velocity (PWV), a non-invasive and reproducible method, predicts cardiovascular morbidity and mortality. The main determinants of arterial stiffness are well established in younger and middle-aged populations, but much less in the elderly. The aim of this study was to describe the determinants of arterial stiffness in elderly apparently healthy subjects. The study included 221 voluntary subjects born before 1944 (mean age 67.475.0 years), who had a standard health check-up at the 'Centre de Mé decine Pré ventive' of Nancy. Arterial stiffness was evaluated by measuring the carotid-femoral PWV with the PulsePen automatic device. Clinical and biological parameters were evaluated at the same day. Measurements were valid and analysed in 207 subjects (94 women). Mean PWV was 9.3972.64 m/s. Men showed higher PWV values than women (9.9972.56 vs 8.6672.56, Po0.001). In univariate analysis, PWV was correlated with age (r ¼ 0.26, Po0.001) and mean arterial pressure (MAP) (r ¼ 0.40, Po0.001), and these relationships were similar in men and women. Subjects with hypertension (Po0.001), diabetes mellitus (Po0.001) and obesity (Po0.01) had higher values of PWV. In multiple regression analysis, PWV correlated positively and independently with age, male gender, MAP and diabetes mellitus. In conclusion, in an apparently healthy elderly population, the main determinants of arterial stiffness are the age, MAP, diabetes and gender. Our study also shows that the gender-related differences in arterial stiffness observed in middle-aged subjects are maintained in the elderly.
Introduction
Increased arterial stiffness has been shown to be an independent predictor of cardiovascular mortality and morbidity. [1] [2] [3] [4] [5] Pulse pressure (PP) has been largely used as an indicator of arterial stiffness. 6, 7 Several studies have shown that PP was correlated with cardiovascular morbidity and mortality. However, PP may be regulated by several other than arterial stiffness parameters, such as cardiac output, wave reflections and peripheral resistance. 8, 9 Direct assessment of proximal arterial stiffness can be performed non-invasively and, therefore, its measurement may be useful as a risk marker. Pulse wave velocity (PWV) is a validated method that has been developed these last years and is now largely used in clinical research. [10] [11] [12] Several recent epidemiological and clinical studies have demonstrated that measuring arterial stiffness provided a higher predictive value than blood pressure (BP) measurement in the evaluation of the cardiovascular risk. 1, 2 Moreover, one recent study showed that in end-stage renal disease patients, the reduction in morbidity and mortality with antihypertensive therapy was only observed in patients whose PWV decreased independently of age and BP evolution. 1, 13 Ageing and high BP are the main determinant of PWV. [14] [15] [16] [17] The increase in aortic stiffness with age occurs gradually and continuously. Cross-sectional 18 and longitudinal 15 studies have shown that aortic PWV increases with age by approximately 0.1 m/s per year (about 1%). Similar changes are observed at the site of the carotid artery. 19 However, some studies have suggested that increase in large artery stiffness follows a nonlinear quadratic evolution, with more pronounced increase after the age of 55 years. 15, 20, 21 This result corroborates the well-known epidemiological observation of an increasing prevalence of systolic hypertension, the main clinical manifestation of large artery stiffness, after the age of 55 years. 7 The effect of gender is also controversial: some studies have shown a stronger increase of arterial stiffness in the elderly women, [22] [23] [24] whereas other studies suggest that the evolution of PWV was similar in the two genders. 15 Among other risk factors, diabetes and renal impairment have been shown to increase significantly PWV. 13, 25 The influence of tobacco smoking and cholesterol level in PWV and arterial stiffness is still controversial. [26] [27] [28] The determinants of arterial stiffness were mainly assessed in studies which included young and middle-aged populations. 14, 18, 19 The determinants of PWV in the elderly have been assessed in a limited number of studies. 3, 12 However, this question is of major clinical interest, as arterial stiffening in the elderly may be a principle determinant of morbidity and mortality in this population.
Therefore, the aim of this study was to describe the main clinical and biological determinants of PWV in ambulatory, living at home, population aged over 60 years, consulting for a medical check-up.
Patients and method
This is a population-based study of 221 consecutive voluntary subjects aged over 60 years old, in apparently good health state, consulting for a medical check-up at the 'Centre de Medecine Preventive' (CMP). The CMP is a medical centre, which is subsidized by the French national health care system and which provides free medical examinations for all working and retired persons and their families. It is one of the largest medical centres of this kind in France, having carried out approximately 20 000-25 000 examinations per year in the people living in the region of Lorraine (East France). People who come for a health check-up are apparently healthy and motivated to be followed up.
In the present study, we included all the subjects aged over 60, who came to the CMP of Nancy during the study period (2 months). In these subjects, we proposed to perform in addition to the standard clinical and biological examination, an evaluation of the PWV with the PulsePen device. All subjects gave their informed consent at the time of the examination.
PWV was not measured for technical reasons in 14 out of these 221 subjects (6.3%). Thus, 207 completed the study and were included in the present report. Among these subjects, anamnesis data are lacking in six (four men and two women), whereas blood was not drawn for biological measurements in six other subjects (three men and three women). In the rest of the subjects, biological parameters were assessed the same day as the clinical parameters.
Applanation tonometry of the common carotid and femoral arteries was used to assess aortic PWV. The study was realized in the 'Centre de Médecine Préventive' of Nancy (France) with logistic support of the 'Centre d'Investigations Cliniques' of the University Hospital of Nancy. We used a new validated, small portable, high-fidelity tonometer (PulsePen) able to measure PWV. The validation of this automatic method and its reproducibility was reported previously. 29 The duration of the examination was generally of 10-15 min for each patient. PulsePen determines the PWV at two intervals in a highly rapid succession: the operator starts positioning the detector at the common carotid artery, the central detection site, while simultaneously performing electrocardiogram (ECG) and tonometry. Then, the same procedure must be followed for the femoral artery. The count for PWV is obtained by the ratio of the distance between the two arteries selected to the difference between the rise delay of the distal pulse wave to the R wave belonging to the ECG qRs complex and the rise delay of the proximal pulse wave to R wave belonging to the ECG qRs complex. The pulse wave delay can be determined by calculating the time elapsed from the peak of qRs complex wave and the 'foot' of pressure pulse waveform. The 'foot' of pressure pulse waveform is determined by the intersection of the horizontal line tangent the lowest point of the pressure waveform following the ECG complex with the extension of the line resulting from the mean-square deviation of all point building up the initial proto-systolic rapid ascending phase of the pressure waveform. To validate measures, we make the condition of a variation lower than 10% for systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR) between the two measurements.
The distances between the measurement sites were assessed with a flexible metre in a straight line. The distance of the pulse wave transit was the difference D1ÀD2 between the distance from suprasternal notch to femoral point of application of the tonometer (inguinal arcade) (D1) and the distance from carotid point of tonometer application and the supra-sternal notch (D2). The PWV was calculated as distance between two points/transit time of the pulse wave.
A minimum of five valid complexes were required. Five records with excessive mean time delay confidence interval (more than710 ms) were eliminated. We also excluded nine patients owing to impossibility to have good quality carotid (four patients) or femoral (five patients) waveforms. No patient presented greater variability than 10% for SBP, DBP or HR between the two measures (carotid and femoral time) and had to be excluded.
BP and HR were obtained by the auscultatory method in the supine position, after a minimal rest period of 10 min. Two measurements were realized for each patient, the first before, and the second after the PWV measurement, and the mean of these two measures was considered in the statistical analysis. Mean arterial blood pressure (MAP) was calculated according formula MAP ¼ As SBP and DBP are influenced by PWV and stiffness, MAP is the only pressure determinant that is not directly influenced by PWV. Therefore, despite some methodological concerns about MAP calculation in the elderly, we believe that this is the best choice we can make under these conditions and MAP was used in this study for statistical adjustments.
Information on health was obtained by medical history, registration of current medication and physical examination. A nurse measured height and weight and calculated the body mass index (BMI) in all 207 subjects. For 186 subjects (90% of the population), we performed the minimental status evaluation (MMSE).
A patient was defined as hypertensive if he presented history of high BP (X140 or X90 mm Hg) at least two times or if he received any antihypertensive treatment. Diabetes was defined as presence of anamnesis of diabetes or presence of an antidiabetic treatment. Dyslipidaemia was also defined according the anamnesis or presence of a cholesterol lowering treatment.
Subjects were classified according to the smoking habits as never smokers, past smokers and current smokers. For the purpose of this analysis, past and current smokers were regrouped.
The day of the examination blood was drawn under fasting conditions for the evaluation of blood glucose, serum cholesterol and serum creatinine level. Subjects were defined as having high serum creatinine level when serum creatinine was X90 mmol/l in women and X120 mmol/l in men. Patients were defined as 'hyperglycaemic' if glucose 46.1 mmol/l and having high cholesterol level when total cholesterol was 45.69 mmol/l.
Statistical analysis was carried out using BMDP software (University of California Press). The population characteristics were expressed as frequencies or means and compared using the w 2 test and F-tests. The relation between PWV and different quantitative variables was studied through linear regression. Different models of multiple regression were then constructed in order to describe the independent significant effects of explanatory variables on the PWV variability.
Results Table 1 shows the main clinical and biological characteristics of this population. Sex ratio was 1.2 with a larger number of men. Mean age was 67.475.0 years, without significant difference between the two genders. Men had higher SBP, DBP and MAP, higher prevalence of diabetes and tobacco smoking, higher glycaemia and creatinine, lower values of HR and of blood cholesterol and lower prevalence of dyslipidaemia.
Seventy-eight out of 201 patients (38.8%) were treated with one to five antihypertensive drugs (40 subjects had a monotherapy, 26 subjects had a bitherapy, eight patients had a three-drug treatment and four patients had four or five antihypertensive drugs). The design of the present cross-sectional study does not allow us the possibility to assess this effect, as we do not have values of PWV before the initiation of the treatment.
In the entire population, mean PWV was 9.3972.64 m/s. PWV was significantly higher in men than in women (9.9972.56 vs 8.6672.56, Po0.001).
In univariate linear analysis, we found that PWV was correlated with age (PWV ¼ 0.154 þ 0.137 * age, Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HR, heart rate; MAP, mean arterial pressure; PP, pulse pressure; PWV, pulse wave velocity; SBP, systolic blood pressure. *n ¼ 201. The relationship between age and PWV was similar when tested with an exponentional analysis (PWV ¼ 3.91e 0.0125 Â r ¼ 0.25). In the entire population, subjects with hypertension (Po0.001), diabetes mellitus (Po0.001), high blood glucose (Po0.001) and obesity (Po0.01) had higher values of PWV as compared to the subgroups without these risk factors ( Table 2) .
History of dyslipidaemia and past or current tobacco smoking, high serum creatinine, high serum cholesterol and high HR were not associated with higher PWV. When the two genders were studied separately, in men, the presence of hypertension and diabetes were associated with higher PWV (both Po0.001). In women, presence of HTA (Po0.05), diabetes (Po0.001), obesity (Po0.01), high blood glucose (Po0.001) and high creatinine values (Po0.05) were all associated with higher PWV. Figure 1 represents the correlations between PWV and age according to gender, hypertensive status and presence of diabetes. Left panel shows the age-PWV relationship in men (solid line) and in women (dotted line). The analysis shows no significant difference in the progression of the PWV with age in the two genders (0.170 m/s annually in men and 0.106 m/s in women). Despite faster progression with age of PWV in hypertensive (0.140 m/s annually) than in normotensive subjects (0.077 m/s), this difference was not statistically significant ( Figure 1, middle panel) . The increase in PWV with age was more important in diabetic than in nondiabetic subjects (0.408 vs 0.105 m/s per year, Po0.01) (Figure 1, right panel) . We also investigated the age/PWV relationship in the two groups according the glucose levels; this analysis showed no difference in the slopes between the two glycaemia groups. Thus in the group of normal glycaemia, the PWV was defined according to age as PWV ¼ 0.18 þ 0.13 * age (r ¼ 0.255 P ¼ 0.001), whereas in the high glycaemia group, this relationship was PWV ¼ 2.55 þ 0.12 * age (r ¼ 0.250, P ¼ 0.131) (data not shown). Abbreviations: BMI, body mass index; HR, heart rate; PWV, pulse wave velocity. a o90 mmol/l in women and o120 mmol/l in men.
b X90 mmol/l in women and X120 mmol/l in men.
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In univariate models, we found no significant relationship between the MMSE score and the PWV (linear correlation between PWV values and MMS score in men (r ¼ À0.054, NS) and women (r ¼ À0.115, NS). The multivariate analysis confirmed the absence of association between PWV and MMSE (after adjustment for age, MBP, diabetes).
Multiple regression analysis between PWV and parameters that were significant in univariate analysis (age, gender, MAP, diabetes and BMI) showed that, in the entire population, age, male gender, MAP and diabetes mellitus were independent determinants of PWV (Table 3 ). According to the multivariate analysis, the determination of PWV is as follows: PWV ¼ À5.88 þ 0.07 * MAP (per mm Hg) þ 2.36 * diabetes (0 ¼ no, 1 ¼ yes) þ 0.14 * age (per year)À0.72 * gender (1 ¼ man, 2 ¼ woman).
This analysis was also performed separately for men and women. In men, the stepwise regression analysis showed that PWV correlated positively and independently with MAP, diabetes mellitus and age. In women, the independent determinants were glycaemia, MAP, blood creatinine and age (data not shown).
Discussion
In an apparently healthy population over 60 years of age, male gender, presence of hypertension, presence of diabetes and advanced age were all significant and independent determinants of increased aortic stiffness assessed by the PVW method.
In this study, we used the PulsePen device for the assessment of the carotid-femoral PWV. Validated in a study vs invasive measurement, 29 this is an efficient device for the non-invasive automatic evaluation of PWV. The PulsePen presents an additional advantage, as it is small in size and can be used by a single person, without additional assistance.
In the present study, the mean annual increase in PWV was approximately 0.14 m/s and the correlation coefficient was r ¼ 0.26. Several studies have shown that the age/PWV relationship is not linear, and when large age ranges are studied, this relationship follows a sigmoidal form. In subjects before the age of 45, the annual increase in PWV is weak (less than 0.10 m/s), indicating low rates of arterial stiffening in young adults; arterial ageing is getting more pronounced for people between 50 and 70 years old reaching a slope of 0.15-0.20 m/s per year. 10, 15, 20, 30 After that age, the increase in PWV is weaker or even absent. A cross-sectional study realized in very old subjects (mean age, 87 years) showed the absence of any relationship between age and PWV. 31 These latter results are probably related to a selection bias, as those very old subjects with the highest PWV present increased morbidity and mortality, and therefore they are not included in clinical studies. [1] [2] [3] Long-term longitudinal studies in the elderly could contribute to better understanding of these observations. In the present analysis, we studied 'young-elderly' subjects (mean age was Abbreviation: MAP, mean arterial pressure.
Aortic stiffness in the elderly C Alecu et al 67 years), which explains that the relationship observed between age and PWV was weaker than the one observed in middle-aged subjects populations, 15, 30 but stronger than the one observed in much older populations. 31 Classically in postmenopausal women, the riskprofile increases rapidly, reaching the level of men after the age of 65 years. 23 It has been shown that women show a more pronounced increase in BP, especially systolic and PP with age, in relation to differences of the geometric characteristics of arterial tree, with a higher increase of arterial stiffness with age in women. 24 In the present study, the mean PP did not vary with gender. Moreover, our study shows that the gender-related differences in arterial stiffness observed in middleaged subjects are maintained in the elderly. Actually, the slope of the age-PWV relationship was even slightly higher in men than in women (0.170 vs 0.106 m/s).
In the present study, we found that among metabolic parameters levels of glycaemia and presence of diabetes were significant determinants of the PWV. Concerning the present data, subjects with high glycaemia had, at any age, higher PWV values, but the age/PWV slopes were not different between high and normal glycaemia subjects. The same type of analysis performed separately in men and women showed similar results, that is, in both genders the glycaemia levels did not influence the slope of the relationships age/PWV. However, the difference in mean PWV values between high and normal glycaemia levels seems to be more pronounced in women than in men. A similar result was also observed for the BMI (Table 2 ). These results suggest that increased stiffness in aged women may be related to metabolic postmenopausal changes, as suggested previously. 16 The higher blood glucose influence in stiffness in women than in men was described in younger women. 22 The PWV increase with BMI was also previously described in younger women. 17 Despite a low number of diabetic patients, in this population history of diabetes influenced significantly and independently arterial stiffness, regardless of the type of diabetes treatment and glycaemia balance. Actually, high PWV was observed even in diabetics with controlled glycaemia levels who represented almost half of the patients of this group. Stiffness was significantly higher in diabetic patients in univariate analysis, and this difference persisted in multivariate models. The PWV increase with age in diabetic patients was almost four times higher than in non-diabetic patients (Figure 1 , slope 0.408 m/s per year vs 0.105, Po0.01). Previous studies have shown the influence of diabetes on arterial stiffness. 16, 17, 25 The physiopathological explication of increased stiffness in diabetics is probably the accelerated formation of advanced glycation end products and collagen crosslinks in the arterial wall of these patients. Surprisingly, the SBP, a clinical indicator of arterial stiffness, is not significantly different between the two groups, probably because of the low number of diabetic patients of this study. This result could suggest that PWV could have a higher sensitivity than SBP in assessing large artery stiffness. This is not really surprising, as SBP depends on cardiac function, arterial geometry, peripheral resistance and large and small artery stiffness, whereas carotid-femoral PWV essentially depends on aortic stiffness. 32 In this population, we observed a high correlation of PWV with MAP (r ¼ 0.40; Po0.00001), persisting in multivariate models. Hypertension is a wellknown determinant of arterial stiffness in middleaged population, 17, 20 and the present study shows that this result is also observed in older subjects.
Dyslipidaemia and tobacco use did not influence significantly arterial stiffness. The role of these two cardiovascular risk factors on arterial stiffness is controversial; most studies have shown the absence of major effect of these two factors on arterial stiffness. 16, 25, [26] [27] [28] Therefore, whereas dyslipidaemia and tobacco have a major role in the atheromatosis process, their contribution to the development of arterial stiffness is not established.
Finally, in this study, we did not find any association between the cognitive status (assessed with the MMSE) and arterial stiffness. In a recent study, Hanon et al. 33 reported a significant association between the severity of the MMSE score decline and PWV in very old subjects with cognitive impairment. Our study shows that such a relationship does not exist in a younger asymptomatic population.
This study shows that male gender, age, high BP and diabetes are the main determinants of aortic PWV in an aged healthy population. Obesity was correlated with higher PWV in women, but not in men. Easy to perform and having a high level of valid examinations (93%), this method to measure arterial rigidity could be included in mass trials for the evaluation of cardiovascular risk, particularly in aged subjects.
